[Use of amixin in the therapy and prevention of some viral infections].
The trial of oral interferon inductor amixin for effectiveness in chronic viral hepatitis (CVH) and hemorrhagic fever with renal syndrome (HFRS) has shown that amixin in CVH improved general condition of the patients, removed yellowness of the skin and sclera, normalized activity of aminotransferases and blood bilirubin level. Virus replication was stopped in 25 and 1.6% in CVHB and CVGC, respectively. Amixin in HFRS was effective if received early. Preventive amixin therapy in population groups with high HFRS risk prevents development of HFRS and acute respiratory viral infection.
Zakirov
I G
IG
D000998:Antiviral Agents / Q000627:therapeutic use*; D006480:Hemorrhagic Fever with Renal Syndrome / Q000188:drug therapy* / Q000517:prevention & control; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000517:prevention & control; D006525:Hepatitis, Viral, Human / Q000188:drug therapy* / Q000517:prevention & control; D006801:Humans; D007369:Interferon Inducers / Q000627:therapeutic use*; D013994:Tilorone / Q000627:therapeutic use*; D016896:Treatment Outcome
D000998:Antiviral Agents; D007369:Interferon Inducers; D013994:Tilorone